US maternal care failings due to ‘focus on reactive care’
The US has access to advanced maternal health technologies, but the mortality rate remains twice as high as other OECD countries.
Corporate Governance
FDA’s final rule on LDTs causes concern, but timeline looks unsteady
Reeves’ 2024 budget promises life sciences investment
US senators raise Pfizer and Eli Lilly telehealth prescribing concerns
As mpox spreads, ‘national governments have a moral responsibility to help’
What is mpox and how big of a threat is it?
‘Everyone is vulnerable’ – how climate change impacts human health
Life sciences in Ireland: new issue of Medical Technology out now
